2701 Eastlake Avenue East
Seattle, WA 98102
United States
206 333 2001
https://www.nautilus.bio
Sector(es): Healthcare
Industria: Biotechnology
Empleados a tiempo completo: 163
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Sujal M. Patel | Co-Founder, CEO, President, Secretary & Director | 827.24k | N/D | 1975 |
Dr. Parag Mallick Ph.D. | Co-Founder, Chief Scientist & Director | 562.8k | N/D | 1978 |
Ms. Anna Mowry | CFO & Treasurer | 519.21k | N/D | 1984 |
Ms. Mary E. Godwin | Senior Vice President of Operations | N/D | N/D | 1959 |
Mr. Matthew B. Murphy ESQ. | General Counsel | 382.64k | N/D | 1965 |
Mr. Chris Blessington | Vice President of Corporate Marketing & Communications | N/D | N/D | N/D |
Ms. Gwen E. Weld | Chief People Officer | 390.97k | N/D | 1958 |
Mr. Nick A. Nelson | Chief Business Officer & Senior VP of Business Development | N/D | N/D | 1984 |
Dr. Subra Sankar Ph.D. | Senior Vice President of Product Development | 38.47k | N/D | 1960 |
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.
La calificación ISS Governance QuickScore de Nautilus Biotechnology, Inc. a partir del 1 de mayo de 2024 es 8. Las puntuaciones principales son Auditoría: 8; Junta: 5; Derechos del accionista: 8; Compensación: 9.